EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
65.50
+1.50 (2.34%)
At close: Oct 9, 2026
| Market Cap | 117.45M +0.4% |
| Revenue (ttm) | 9.54M -1.8% |
| Net Income | 2.83M +118.1% |
| EPS | 1.59 +119.8% |
| Shares Out | 1.79M |
| PE Ratio | 41.24 |
| Forward PE | n/a |
| Dividend | 2.00 (3.05%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 102 |
| Open | 64.00 |
| Previous Close | 64.00 |
| Day's Range | 64.00 - 65.50 |
| 52-Week Range | 59.00 - 69.00 |
| Beta | -0.01 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 21, 2026 |